XT
Xtant Medical Holdings, Inc.
XTNT · AMEX
$0.34 -11.34% (-$0.04)
1M +18.78%
Market Cap $47.3M
P/E Ratio -
Div. Yield -
ROE 23.45%
Bulios Fair Price
$0.36
6.8% upside
Current Price
$0.34
Undervalued Fair Value Overvalued
According to Bulios Fair Price, XTNT is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.43x
P/B 1.18x
P/E N/A
Growth
100 /100
Growing Rev. growth 32.20%
Book val. growth 14.25%
EPS growth N/A
Profitability
21 /100
Weak Gross margin 59.39%
Net margin 10.17%
Op. margin 9.58%
Quality
15 /100
Poor ROIC 19.16%
ROE 23.45%
ROA 13.98%
Debt
56 /100
Moderate Debt/Equity 0.65x
Current ratio 2.16x
Int. coverage -2.34x
Stability
31 /100
Unstable Beta -0.15x
Rev. volatility 22.07%
EPS volatility 1,456.73%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about XTNT
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Sean E. Browne
Employees
151
Headquarters
Belgrade
Upcoming events
10 NOV
Earnings
Upcoming earnings report